602 related articles for article (PubMed ID: 19699238)
1. Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis.
Wang YF; Wang XY; Ren Z; Qian CW; Li YC; Kaio K; Wang QD; Zhang Y; Zheng LY; Jiang JH; Yang CR; Liu Q; Zhang YJ; Wang YF
Antiviral Res; 2009 Nov; 84(2):150-8. PubMed ID: 19699238
[TBL] [Abstract][Full Text] [Related]
2. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
[TBL] [Abstract][Full Text] [Related]
3. Anti-coxsackie virus B3 norsesquiterpenoids from the roots of Phyllanthus emblica.
Liu Q; Wang YF; Chen RJ; Zhang MY; Wang YF; Yang CR; Zhang YJ
J Nat Prod; 2009 May; 72(5):969-72. PubMed ID: 19374435
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of 20(s)-protopanaxtriol on viral myocarditis infected by coxsackievirus B3.
Wang X; Wang Y; Ren Z; Qian C; Li Y; Wang Q; Zhang Y; Zheng L; Jiang J; Yang C; Wang D; Zhang Y; Fan J; Wang Y
Pathobiology; 2012; 79(6):285-9. PubMed ID: 22688124
[TBL] [Abstract][Full Text] [Related]
5. [Effect of a C-type CpG ODN on CVB3-infected mice].
Yang L; Sun WQ; Wang L; Wang XL; Wan M; Yu YL; Wang LY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Feb; 25(2):115-7. PubMed ID: 19174007
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.
Yun SH; Lee WG; Kim YC; Ju ES; Lim BK; Choi JO; Kim DK; Jeon ES
J Infect Dis; 2012 Feb; 205(3):491-7. PubMed ID: 22207647
[TBL] [Abstract][Full Text] [Related]
7. The heart-protective mechanism of Qishaowuwei formula on murine viral myocarditis induced by CVB3.
Fengqin L; Yulin W; Xiaoxin Z; Youpeng J; Yan C; Qing-qing W; Hong C; Jia S; Lei H
J Ethnopharmacol; 2010 Feb; 127(2):221-8. PubMed ID: 19932162
[TBL] [Abstract][Full Text] [Related]
8. [Effect of Chinese herbal medicine Xin-kang oral liquid on interferon-induction and its antiviral activity in coxsackievirus B3 infected mice].
Wan SJ; Li JN; Zhao H; Wang LX; Huang XZ; Zhu Y; Chen HS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):77-9. PubMed ID: 16201482
[TBL] [Abstract][Full Text] [Related]
9. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
Stein EA; Pinkert S; Becher PM; Geisler A; Zeichhardt H; Klopfleisch R; Poller W; Tschöpe C; Lassner D; Fechner H; Kurreck J
J Infect Dis; 2015 Feb; 211(4):613-22. PubMed ID: 25193982
[TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effect of Chinese herbal medicine Xin-Kang oral liquid on replication of CVB3 RNA in Coxsackievirus B3 infected mice].
Wan SJ; Yang F; Huang XZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):238-40. PubMed ID: 17971932
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro antiviral activities of calycosin-7-O-beta-D-glucopyranoside against coxsackie virus B3.
Zhu H; Zhang Y; Ye G; Li Z; Zhou P; Huang C
Biol Pharm Bull; 2009 Jan; 32(1):68-73. PubMed ID: 19122283
[TBL] [Abstract][Full Text] [Related]
12. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.
Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M
Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210
[TBL] [Abstract][Full Text] [Related]
13. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
[TBL] [Abstract][Full Text] [Related]
14. Effect of verapamil on acute coxsackievirus B3 murine myocarditis.
Xu Y; Yang YZ; Chen HZ; Jin PY; Guo Q; Zhao WZ; Yang JH; Cai QX; Zhou YC
Chin Med J (Engl); 1992 Oct; 105(10):818-21. PubMed ID: 1337875
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo antiviral activity of a fluoronucleoside analog, NCC, against Coxsackie virus B3.
Wang Y; Zhuan X; Peng Y; Li Q; Huang C; Huang H; Liang Z; Wang Q; Chang J
Acta Virol; 2021; 65(1):58-67. PubMed ID: 33827222
[TBL] [Abstract][Full Text] [Related]
16.
Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
[TBL] [Abstract][Full Text] [Related]
17. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice.
Jiang Y; Zhu R; Luo L; Mu Q; Zhu Y; Luo H; Zou X; Shen X
Intervirology; 2015; 58(6):343-9. PubMed ID: 26829552
[TBL] [Abstract][Full Text] [Related]
18. [Minor Bupleurum decoction in the treatment of viral myocarditis models].
Wang X; Zhang G; Liang Y; Chen C; Qiu S
Zhongguo Zhong Yao Za Zhi; 1997 Nov; 22(11):684-6, 704. PubMed ID: 11243188
[TBL] [Abstract][Full Text] [Related]
19. Shenqi fuzheng injection improves cvb3-induced myocarditis via inhibiting traf6 expression.
Chen J; Wang Z; Wu T
Cell Mol Biol (Noisy-le-grand); 2013 Feb; 59 Suppl():OL1826-34. PubMed ID: 23374452
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
